Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose RNA editing generates protein diversity by altering RNA sequences in coding regions without changing the overall DNA sequence. Adenosine-to-inosine (A-to-I) RNA editing events have recently been reported in some types of cancer, but they are rare in human colorectal cancer (CRC). Therefore, this study was conducted to identify diverse RNA editing in CRC. Materials and Methods We compared transcriptome data of 39 CRC samples and paired adjacent tissues from The Cancer Genome Atlas database to identify RNA editing patterns in CRC, focusing on canonical A-to-I RNA edits in coding sequence regions. We investigated nonsynonymous RNA editing patterns by comparing tumor and normal tissue transcriptome data. Results The number of RNA edits varied from 12 to 42 per sample. We also observed that hypoand hyper-RNA editing patterns were distinguishable within the samples. We found 10 recurrent nonsynonymous RNA editing candidates in nine genes (PDLIM, NEIL1, SRP9, GLI1, APMAP, IGFBP7, ZNF358, COPA, and ZNF587B) and validated some by Sanger sequencing and the inosine chemical erasing assay. We further showed that editing at these positions was performed by the adenosine deaminase acting on RNA 1 enzyme. Most of these genes are hypoedited in CRC, but editing of GLI1 was increased in cancer tissues compared with normal tissues. Conclusion Our results show that nonsynonymous RNA editing patterns can be used to identify CRC patients and could serve as novel biomarkers for CRC.
Abstract
Purpose RNA editing generates protein diversity by altering RNA sequences in coding regions without changing the overall DNA sequence. Adenosine-to-inosine (A-to-I) RNA editing events have recently been reported in some types of cancer, but they are rare in human colorectal cancer (CRC). Therefore, this study was conducted to identify diverse RNA editing in CRC. Materials and Methods We compared transcriptome data of 39 CRC samples and paired adjacent tissues from The Cancer Genome Atlas database to identify RNA editing patterns in CRC, focusing on canonical A-to-I RNA edits in coding sequence regions. We investigated nonsynonymous RNA editing patterns by comparing tumor and normal tissue transcriptome data. Results The number of RNA edits varied from 12 to 42 per sample. We also observed that hypoand hyper-RNA editing patterns were distinguishable within the samples. We found 10 recurrent nonsynonymous RNA editing candidates in nine genes (PDLIM, NEIL1, SRP9, GLI1, APMAP, IGFBP7, ZNF358, COPA, and ZNF587B) and validated some by Sanger sequencing and the inosine chemical erasing assay. We further showed that editing at these positions was performed by the adenosine deaminase acting on RNA 1 enzyme. Most of these genes are hypoedited in CRC, but editing of GLI1 was increased in cancer tissues compared with normal tissues. Conclusion Our results show that nonsynonymous RNA editing patterns can be used to identify CRC patients and could serve as novel biomarkers for CRC.
참고문헌 (30)
- Greenman C, "Patterns of somatic mutation in human cancer genomes", Nature, 446, pp.153~158 (2007)
- Cancer Genome Atlas Network, "Comprehensive molecular characterization of human colon and rectal cancer", Nature, 487, pp.330~337 (2012)
- Keegan LP, "The many roles of an RNA editor", Nat Rev Genet, 2, pp.869~878 (2001)
- Nishikura K, "Editor meets silencer : crosstalk between RNA editing and RNA interference", Nat Rev Mol Cell Biol, 7, pp.919~931 (2006)
- Nishikura K, "Functions and regulation of RNA editing by ADAR deaminases", Annu Rev Biochem, 79, pp.321~349 (2010)
- Ju YS, "Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals", Nat Genet, 43, pp.745~752 (2011)
- Li M, "Widespread RNA and DNA sequence differences in the human transcriptome", Science, 333, pp.53~58 (2011)
- Ramaswami G, "RADAR: a rigorously annotated database of A-to-I RNA editing", Nucleic Acids Res, 42, pp.D109~D113 (2014)
- Kiran A, "DARNED : a DAtabase of RNa EDiting in humans", Bioinformatics, 26, pp.1772~1776 (2010)
- Kleinman CL, "RNA editing of protein sequences : a rare event in human transcriptomes", RNA, 18, pp.1586~1596 (2012)
- Paz N, "Altered adenosine-to-inosine RNA editing in human cancer", Genome Res, 17, pp.1586~1595 (2007)
- Cenci C, "Down-regulation of RNA editing in pediatric astrocytomas : ADAR2 editing activity inhibits cell migration and proliferation", J Biol Chem, 283, pp.7251~7260 (2008)
- Maas S, "Underediting of glutamate receptor GluR-B mRNA in malignant gliomas", Proc Natl Acad Sci U S A, 98, pp.14687~14692 (2001)
- Chen L, "Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma", Nat Med, 19, pp.209~216 (2013)
- Han SW, "RNA editing in RHOQ promotes invasion potential in colorectal cancer", J Exp Med, 211, pp.613~621 (2014)
- Koboldt DC, "VarScan 2 : somatic mutation and copy number alteration discovery in cancer by exome sequencing", Genome Res, 22, pp.568~576 (2012)
- Wang K, "ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data", Nucleic Acids Res, 38, pp.e164~ (2011)
- Sakurai M, "Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome", Nat Chem Biol, 6, pp.733~740 (2010)
- Oh JH, "Establishment and characterization of 12 human colorectalcarcinoma cell lines", Int J Cancer, 81, pp.902~910 (1999)
- Han L, "The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers", Cancer Cell, 28, pp.515~528 (2015)
- Maas S, "A-to-I RNA editing : recent news and residual mysteries", J Biol Chem, 278, pp.1391~1394 (2003)
- Piskol R, "Lack of evidence for existence of noncanonical RNA editing", Nat Biotechnol, 31, pp.19~20 (2013)
- Yeo J, "RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1", Proc Natl Acad Sci U S A, 107, pp.20715~20719 (2010)
- Shah SP, "Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution", Nature, 461, pp.809~813 (2009)
- Verhagen HJ, "IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival", Cell Death Dis, 5, pp.e1300~ (2014)
- Liu L, "Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients", Tumour Biol, 35, pp.8875~8881 (2014)
- Chan TH, "A disrupted RNA editing balance mediated by ADARs(Adenosine DeAminases that act on RNA)in human hepatocellular carcinoma", Gut, 63, pp.832~843 (2014)
- Shimokawa T, "RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling", RNA Biol, 10, pp.321~333 (2013)
- Bar EE, "Hedgehog signaling promotes medulloblastoma survival via Bc", II, 2007, pp.170, 347~355
- Akiyoshi T, "Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation", Gut, 55, pp.991~999 (2006)